Aaron M. Erter
Known title: CEOCIK: 0001713958
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Ball Corp. Eyes Q3 Earnings Amid Analyst Optimism. Ball Corporation is approaching its Q3 earnings release. Analysts are discussing whether recent optimism about margins and cash flow will hold, with some suggesting the stock may be undervalued while others remain skeptical. A separate report notes that Ball is not likely to make an offer for Ardagh Metal. The earnings focus adds attention to the stock as investors await the results.
Transaction History
| JHX | ▲ Buy | Grant | 60,588 | $0 | 8/20/2026 | View on chart |
| JHX | ▲ Buy | Grant | 59,972 | $0 | 8/17/2026 | View on chart |
| JHX | ▼ Sell | Tax Withholding | 25,217 | $767K | 8/17/2026 | View on chart |
| BALL | ▲ Buy | Option Exercise | 3,369 | $0 | 4/30/2026 | View on chart |
| BALL | ▲ Buy | Option Exercise | 2,154 | $0 | 6/3/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Baird Lowers James Hardie Target to $32 While Maintaining Outperform
Baird kept its Outperform rating for James Hardie but cut its price target to $32 from a higher level. The move reflects a more cautious view on the company’s valuation, even as the firm remains a top pick in the sector. The stock is trading near its 200‑day moving average and has a positive RSI divergence, suggesting some upside potential. Analysts still see a target range up to $40, so the outlook remains mixed.
Baird Lowers James Hardie Target to $32 While Maintaining Outperform. Baird kept its Outperform rating for James Hardie but cut its price target to $32 from a higher level. The move reflects a more cautious view on the company’s valuation, even as the firm remains a top pick in the sector. The stock is trading near its 200‑day moving average and has a positive RSI divergence, suggesting some upside potential. Analysts still see a target range up to $40, so the outlook remains mixed.